Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Carr

Showing results (211-220 of 289) with videos related to

Pageof 29
Sort By:
Annals of the Rheumatic Diseases|August 21, 2010
Meta-analyses of genes modulating intracellular T3 bio-availability reveal a possible role for the DIO3 gene in osteoarthritis susceptibilityIngrid Meulenbelt, Steffan D Bos, Kay Chapman, et al.
International Journal of Epidemiology|July 27, 2007
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected menMargaret May, Jonathan A C Sterne, Martin Shipley, et al.
Sexual Health|December 13, 2021
Overcoming barriers to HIV pre-exposure prophylaxis (PrEP) coverage in Australia among Medicare-ineligible people at risk of HIV: results from the MI-EPIC clinical trialCurtis Chan, Doug Fraser, Stefanie Vaccher, et al.
Plos One|September 7, 2013
Opt-out and opt-in testing increases syphilis screening of HIV-positive men who have sex with men in AustraliaRebecca Guy, Carol El-Hayek, Christopher K Fairley, et al.
BMJ Open|July 22, 2018
LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependenceNadine Ezard, Adrian Dunlop, Michelle Hall, et al.
AIDS and Behavior|October 5, 2018
High Adherence to HIV Pre-exposure Prophylaxis and No HIV Seroconversions Despite High Levels of Risk Behaviour and STIs: The Australian Demonstration Study PrELUDEIryna B Zablotska, Stefanie J Vaccher, Mark Bloch, et al.
Health Technology Assessment (Winchester, England)|May 6, 2020
Total versus partial knee replacement in patients with medial compartment knee osteoarthritis: the TOPKAT RCTDavid J Beard, Loretta J Davies, Jonathan A Cook, et al.
Lancet (London, England)|July 22, 2019
The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trialDavid J Beard, Loretta J Davies, Jonathan A Cook, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 20, 2002
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panelMorris Schambelan, Constance A Benson, Andrew Carr, et al.
AIDS Research and Human Retroviruses|December 5, 2018
HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen ExposureWilliam J Hey-Nguyen, Michelle Bailey, Yin Xu, et al.
Pageof 29

Showing results (211-220 of 289) with videos related to

Sort By:
Pageof 29
Annals of the Rheumatic Diseases|August 21, 2010
Meta-analyses of genes modulating intracellular T3 bio-availability reveal a possible role for the DIO3 gene in osteoarthritis susceptibilityIngrid Meulenbelt, Steffan D Bos, Kay Chapman, et al.
International Journal of Epidemiology|July 27, 2007
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected menMargaret May, Jonathan A C Sterne, Martin Shipley, et al.
Sexual Health|December 13, 2021
Overcoming barriers to HIV pre-exposure prophylaxis (PrEP) coverage in Australia among Medicare-ineligible people at risk of HIV: results from the MI-EPIC clinical trialCurtis Chan, Doug Fraser, Stefanie Vaccher, et al.
Plos One|September 7, 2013
Opt-out and opt-in testing increases syphilis screening of HIV-positive men who have sex with men in AustraliaRebecca Guy, Carol El-Hayek, Christopher K Fairley, et al.
BMJ Open|July 22, 2018
LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependenceNadine Ezard, Adrian Dunlop, Michelle Hall, et al.
AIDS and Behavior|October 5, 2018
High Adherence to HIV Pre-exposure Prophylaxis and No HIV Seroconversions Despite High Levels of Risk Behaviour and STIs: The Australian Demonstration Study PrELUDEIryna B Zablotska, Stefanie J Vaccher, Mark Bloch, et al.
Health Technology Assessment (Winchester, England)|May 6, 2020
Total versus partial knee replacement in patients with medial compartment knee osteoarthritis: the TOPKAT RCTDavid J Beard, Loretta J Davies, Jonathan A Cook, et al.
Lancet (London, England)|July 22, 2019
The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trialDavid J Beard, Loretta J Davies, Jonathan A Cook, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 20, 2002
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panelMorris Schambelan, Constance A Benson, Andrew Carr, et al.
AIDS Research and Human Retroviruses|December 5, 2018
HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen ExposureWilliam J Hey-Nguyen, Michelle Bailey, Yin Xu, et al.
Pageof 29